Literature DB >> 33594253

Applying speech technologies to assess verbal memory in patients with serious mental illness.

Terje B Holmlund1, Chelsea Chandler2, Peter W Foltz2,3, Alex S Cohen4, Jian Cheng5, Jared C Bernstein5, Elizabeth P Rosenfeld5, Brita Elvevåg6,7.   

Abstract

Verbal memory deficits are some of the most profound neurocognitive deficits associated with schizophrenia and serious mental illness in general. As yet, their measurement in clinical settings is limited to traditional tests that allow for limited administrations and require substantial resources to deploy and score. Therefore, we developed a digital ambulatory verbal memory test with automated scoring, and repeated self-administration via smart devices. One hundred and four adults participated, comprising 25 patients with serious mental illness and 79 healthy volunteers. The study design was successful with high quality speech recordings produced to 92% of prompts (Patients: 86%, Healthy: 96%). The story recalls were both transcribed and scored by humans, and scores generated using natural language processing on transcriptions were comparable to human ratings (R = 0.83, within the range of human-to-human correlations of R = 0.73-0.89). A fully automated approach that scored transcripts generated by automatic speech recognition produced comparable and accurate scores (R = 0.82), with very high correlation to scores derived from human transcripts (R = 0.99). This study demonstrates the viability of leveraging speech technologies to facilitate the frequent assessment of verbal memory for clinical monitoring purposes in psychiatry.

Year:  2020        PMID: 33594253     DOI: 10.1038/s41746-020-0241-7

Source DB:  PubMed          Journal:  NPJ Digit Med        ISSN: 2398-6352


  2 in total

1.  Using Machine Learning in Psychiatry: The Need to Establish a Framework That Nurtures Trustworthiness.

Authors:  Chelsea Chandler; Peter W Foltz; Brita Elvevåg
Journal:  Schizophr Bull       Date:  2020-01-04       Impact factor: 9.306

2.  Memory impairment in schizophrenia: a meta-analysis.

Authors:  A Aleman; R Hijman; E H de Haan; R S Kahn
Journal:  Am J Psychiatry       Date:  1999-09       Impact factor: 18.112

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.